Amino-Terminal Phosphorylation of Activation-Induced Cytidine Deaminase Suppresses c-myc/IgH Translocation
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amino-Terminal Phosphorylation of Activation-Induced Cytidine Deaminase Suppresses c-myc/IgH Translocation
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 31, Issue 3, Pages 442-449
Publisher
American Society for Microbiology
Online
2010-12-07
DOI
10.1128/mcb.00349-10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Origin of Chromosomal Translocations in Lymphoid Cancer
- (2010) André Nussenzweig et al. CELL
- Activation-Induced Cytidine Deaminase Targets DNA at Sites of RNA Polymerase II Stalling by Interaction with Spt5
- (2010) Rushad Pavri et al. CELL
- The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia
- (2009) Lars Klemm et al. CANCER CELL
- AID Produces DNA Double-Strand Breaks in Non-Ig Genes and Mature B Cell Lymphomas with Reciprocal Chromosome Translocations
- (2009) Davide F. Robbiani et al. MOLECULAR CELL
- From Promiscuity to Precision: Protein Phosphatases Get a Makeover
- (2009) David M. Virshup et al. MOLECULAR CELL
- Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination
- (2009) Bao Q Vuong et al. NATURE IMMUNOLOGY
- Active nuclear import and cytoplasmic retention of activation-induced deaminase
- (2009) Anne-Marie Patenaude et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity
- (2009) Meng Wang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice
- (2009) Hwei-Ling Cheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Balancing AID and DNA repair during somatic hypermutation
- (2009) Man Liu et al. TRENDS IN IMMUNOLOGY
- The Biochemistry of Somatic Hypermutation
- (2008) Jonathan U. Peled et al. Annual Review of Immunology
- Mechanism and Regulation of Class Switch Recombination
- (2008) Janet Stavnezer et al. Annual Review of Immunology
- Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
- (2008) Danilo Perrotti et al. CANCER AND METASTASIS REVIEWS
- AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations
- (2008) Davide F. Robbiani et al. CELL
- MicroRNA-155 Is a Negative Regulator of Activation-Induced Cytidine Deaminase
- (2008) Grace Teng et al. IMMUNITY
- MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation
- (2008) Yair Dorsett et al. IMMUNITY
- Impact of Phosphorylation and Phosphorylation-null Mutants on the Activity and Deamination Specificity of Activation-induced Cytidine Deaminase
- (2008) Phuong Pham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of class switch recombination and somatic mutation by AID phosphorylation
- (2008) Kevin M. McBride et al. JOURNAL OF EXPERIMENTAL MEDICINE
- miR-181b negatively regulates activation-induced cytidine deaminase in B cells
- (2008) Virginia G. de Yébenes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Proteasomal degradation restricts the nuclear lifespan of AID
- (2008) Said Aoufouchi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Two levels of protection for the B cell genome during somatic hypermutation
- (2008) Man Liu et al. NATURE
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More